Shire has announced the voluntary market withdrawal of a limited amount of its Daytrana patch, which is used to treat attention-deficit hyperactivity disorder.
Only Daytrana packages with an expiration date of March 31, 2009, or earlier and packages with lot numbers 2563511, 2563611, and 2570411 are affected.
Shire is taking this step because of feedback from patients and caregivers who have experienced difficulty removing the release liner from some of the patches.
The company expects the patches that are not subject to the withdrawal and those that have been manufactured via an enhanced process to offer improved ease of use when the release liner is peeled off the patch. The current supply levels of Daytrana are sufficient to ensure that patients can have their prescriptions filled with the easier to-use patch.
(Source: Shire, September 4, 2007)